We Deliver
We deliver high-quality, affordable medicines to more than 100 million people in Europe and beyond.
Our medical representatives across Western and Central & Eastern Europe work closely with healthcare professionals, pharmacists, healthcare decision-makers, and tender organizations, implementing tailored strategies for each European market. In 2024, we signed more than 75 business development agreements to expand our portfolio and successfully launched 140 products across Europe. Through Zent2U, we offer specialized services for B2B partners, with expertise in cardiology, urology, oncology, neurology, and hormones. Additionally, Prague Scientific, provides pharmacovigilance and regulatory services for both prescription (RX), non-prescription (OTC), and non-medicinal products.
Zent2U - our B2B business
At the heart of our growth plan, we have placed Zent2U - our B2B business. As cost leaders in Cardiology, Urology, Oncology and Neurology and specialized in Hormones, Steriles and Pellet technologies, we are working towards a broader access of high-quality and affordable medicines. We demonstrate a high operational intensity, transferring over 80 products per year and benefit from our development and global regulatory experience.
Zent2U is offering:
For more information about Zent2U, please visit our dedicated website: Home | Zent2U